section name header

Other Information

Melasma!!navigator!!

Basics

  • Formerly known as chloasma, melasma, or the “mask of pregnancy,” is an acquired form of hyperpigmentation arising most often on the face.

  • It is rare before puberty and most commonly occurs in women during their reproductive years, particularly those who have darker complexions and live in sunny climates.

  • Melasma is seen in Asia, the Middle East, South America, Africa, and the Indian subcontinent. In North America, it is most prevalent among Hispanics, African-Americans, and immigrants from countries in which it is common.

  • It may appear during pregnancy, from oral contraceptive use, during menopause, or it may arise de novo for no apparent reason.

  • Melasma is exacerbated by exposure to sunlight.

  • When men are affected, the clinical and histologic picture is identical; however, the explanation for this condition in males is unknown.

Clinical Manifestations

  • Primarily a cosmetic problem consisting of asymptomatic, blotchy darkening of the facial skin.

  • Lesions are found mainly on the cheeks, angles of the jaw, forehead, nose, chin, and above the upper lip (Fig. 23.10).

  • The hyperpigmentation often follows the rim of the zygomatic arch and the nasolabial fold is generally spared (Fig. 23.11).

  • Lesions are tan to brown, hyperpigmented macules that may coalesce into symmetric, well-demarcated patches.

  • During pregnancy, the darkening of the skin often occurs in the second and third trimesters and most often spontaneously fades after termination of pregnancy.

  • Melasma also tends to fade on discontinuance of oral contraceptives or avoidance of sunlight; however, it may persist indefinitely.

Diagnosis-icon.jpg Differential Diagnosis

Postinflammatory Hyperpigmentation (see the Discussion below)
  • Previous inflammatory eruption or injury. In general, lesions roughly correspond to the location of inflammation or injury and have less clearly defined margins than seen in melasma.

Solar Lentigines (“Liver Spots”)

Management-icon.jpg Management

  • Treatment of melasma often involves a combination approach using one or more bleaching agents, cosmetic camouflage, and meticulous sun avoidance and blockage.

  • Bleaching creams that contain the tyrosinase inhibitor hydroquinone are readily available and are an effective first-line treatment for melasma.

  • Over-the-counter preparations such as Ambi and Esoterica contain 2% hydroquinone.

  • Preparations of 3% hydroquinone (Melanex) and 4% hydroquinone (Eldoquin Forte) are available by prescription only. Some products such as Eldopaque also contain a sunblock; Lustra, a 4% hydroquinone agent, also contains vitamins C and E and glycolic acid.

  • Hydroquinone preparations are applied twice daily to areas of darkening only.

  • Other lightening agents include the tyrosinase inhibitor azelaic acid (Azelex 20% cream), which may be used in addition to hydroquinone.

  • Topical tretinoin can also be used in combination with both hydroquinone and a topical steroid (Tri-Luma cream).

  • Alpha-hydroxy acid products, such as mild glycolic acid peels, may also be used to hasten the effect of other topical lightening agents. They should be used cautiously in darkly pigmented Hispanics, Asians, and blacks because of the risk for postinflammatory pigmentary hyperpigmentation (see the next section).

  • Kojic acid, a tyrosinase inhibitor, is commonly used in Japan and the Middle East, and it seems to have an efficacy similar to that of hydroquinone.

Helpful-Hint-icon.jpg Helpful Hints

  • Lightening agents work slowly and results may not be visible for months. Therefore patience is required.

  • Without the strict avoidance of sunlight, potentially successful treatments for melasma are doomed to failure.

  • Destructive modalities (e.g., cryotherapy, medium-depth chemical peels, lasers) yield unpredictable results and are associated with numerous potential adverse effects.

SEE PATIENT HANDOUT “Melasma” IN THE COMPANION eBOOK EDITION.

Postinflammatory Hyperpigmentation !!navigator!!

Basics

  • Darkening of the skin may occur after nearly any inflammatory eruption, such as eczema (Figs. 23.12 and 23.13), lichen planus, acne, or after an injury to the skin such as a burn. Elective skin treatments (e.g., chemical peels, laser resurfacing, or dermabrasion) may also precipitate postinflammatory hyperpigmentation.

  • The hyperpigmentation stems from the melanocyte's exaggerated response to cutaneous insult, which results in an increased or abnormal distribution of the pigment melanin.

  • As with melasma, postinflammatory hyperpigmentation tends to develop more often in people with dark complexions.

Clinical Manifestations

  • As in postinflammatory hypopigmentation (discussed above), this is an asymptomatic cosmetic issue.

  • Lesions tend to conform in location and shape to the preceding eruption or injury (Fig. 23.14A,B).

  • May be exacerbated by sun exposure.

Management-icon.jpg Management

  • Often, the passage of time, coupled with sun protection, affords a gradual lightening of darkened areas.

  • Avoidance and treatment of the inciting underlying dermatosis may prevent future lesions. Treatment of acne, for example, prevents the formation of new inflammatory lesions and allows time for older pigmented lesions to fade.

  • When lesions persist, many of the measures used to treat melasma (see the discussion above) may be tried. Agents such as azelaic acid, topical retinoids such as Tazorac 0.1% cream in addition to an agent containing a hydroquinone may be of some benefit; however, persistent postinflammatory hyperpigmentation tends to be much more recalcitrant than is melasma.

  • Cosmetic cover-ups may be used.

Phytophotodermatitis and Berloque Dermatitis !!navigator!!

Basics

  • Phytophotodermatitis is a phototoxic reaction that results from contact with a photosensitizing agent followed by sun exposure.

  • Photosensitizing chemicals are called furocoumarins and are commonly found in several citrus fruits and plants, including lemons, limes, bergamot oranges, grapefruit, celery, parsley, parsnip, and hogweed.

  • The reaction is a chemically induced, nonimmunologic, acute skin reaction requiring light (usually within the UVA spectrum; i.e., 320 to 400 nm).

  • A botanical cause for dermatitis is suspected when the pattern of an eruption is linear or streaky, such as noted in the contact dermatitis caused by poison ivy (see Chapter 13: Eczema and Related Disorders).

  • When the phytophotodermatitis is caused by perfume or other agents such as oil from the bergamot lime (Citrus bergamia), an ingredient in some perfumes and fragrances, it is referred to as berloque dermatitis.

Clinical Manifestations

  • The initial skin response resembles an exaggerated sunburn which may be accompanied by blisters (Fig. 23.15A). The reaction typically begins within 24 hours of exposure and peaks at 48 to 72 hours.

  • Postinflammatory hyperpigmentation that may last several weeks or longer typically ensues (Fig. 23.15B).

Helpful-Hint-icon.jpg Helpful Hints

  • Limes are a common culprit of phytophotodermatitis and characteristically appear as a stippled pattern localized to the first dorsal interosseous area of the hand(s).

  • Ask the patient if he or she was squeezing lemons or limes on chicken or fish while outdoor barbequing.

Poikiloderma of Civatte !!navigator!!

Basics

  • This common condition occurs primarily in middle-aged, fair-skinned women.

  • Hormonal changes related to menopause or low estrogen levels may be a causal factor.

Clinical Manifestations

  • Basically of cosmetic concern to patients.

  • Lesions consist of erythema associated with a mottled pigmentation located on the sides of the neck and other sun-exposed areas.

  • The shaded submental and submandibular areas are usually spared, supporting chronic sunlight exposure as the apparent cause of this condition (Fig. 23.16).

Management-icon.jpg Management

  • The patient should be advised about avoidance of sun exposure and the proper use of sunscreens to prevent further skin involvement.

  • The pulsed-dye laser may be used to decrease the erythema in this condition.

Confluent and Reticulated Papillomatosis (Gougerot-Carteaud Disease) !!navigator!!

Basics

  • Confluent and reticulated papillomatosis (CARP) is an uncommon condition of unknown etiology. Causal theories include an endocrine disruption, a disorder of keratinization, and an abnormal host reaction to Pityrosporum organisms or bacteria.

Clinical Manifestations

  • CARP usually presents shortly after puberty.

  • CARP is characterized by hyperkeratotic papules and plaques that coalesce to form hyperpigmented, confluent plaques centrally with a reticular pattern peripherally (Fig. 23.17).

  • CARP is usually located on the trunk, back, lateral or posterior neck or the flanks (Fig. 23.18).

  • Lesional skin is “rough” textured on palpation.

Diagnosis

  • Clinical appearance is characteristic and a KOH is negative.

Diagnosis-icon.jpg Differential Diagnosis

Acanthosis Nigricans(see the following section)
  • Indistinguishable from CARP histopathologically.

Darkly Pigmented Tinea Versicolor
  • KOH positive, not “rough” textured on palpation.

Management-icon.jpg Management

  • CARP responds to oral tetracyclines, such as minocycline or doxycycline 100 mg twice a day for 2 to 3 months.

Helpful-Hint-icon.jpg Helpful Hint

  • Many patients with CARP also have coexistent acanthosis nigricans (see below).

Acanthosis Nigricans !!navigator!!

Basics

  • Acanthosis nigricans (AN) has a characteristic hyperpigmented skin pattern that occurs primarily in flexural folds. The skin is thought to darken and thicken in reaction to circulating growth factors and insulin resistance.

  • The majority of cases of AN, including idiopathic cases and those associated with obesity, are referred to as benign AN.

  • Other benign forms of AN are associated with endocrine disorders, such as insulin-resistant diabetes, polycystic ovary syndrome, Cushing disease, Addison disease, pituitary tumors, pinealomas, and hyperandrogenic syndromes with insulin resistance.

  • AN is sometimes related to drug use, most commonly secondary to glucocorticoids, nicotinic acid, diethylstilbestrol, or growth hormone therapy. AN may also be inherited without any disease associations.

  • The rare, so-called malignant AN is associated with an internal malignant disease, usually an intra-abdominal adenocarcinoma. Affected patients generally have a poor prognosis. The skin condition is sometimes seen before the cancer is recognized; it can also be associated with recurrences and metastases.

Clinical Manifestations

  • AN generally presents with a gradual evolution of symmetric, asymptomatic, tan or brown to black, leathery or velvety plaques.

  • Plaques are sometimes “warty” (papillomatous) and studded with skin tags.

  • They have linear, alternating, dark and light pigmentation that becomes more apparent when the skin is stretched (Fig. 23.19).

  • The most common sites of involvement are the axillae, the base of the neck, the inframammary folds, the inguinal areas, and the antecubital fossae (Fig. 23.20).

  • The dorsa of the hands (especially the knuckles), the elbows, and the knees are also common locations.

  • Less commonly, mucous membranes, the vermilion border of the lips, and the eyelids are involved.

Management-icon.jpg Management

  • The underlying etiology of AN should be investigated and addressed.

  • Common interventions include correcting hyperinsulinemia through diet and medication; weight loss for obesity-associated AN; excise or treat any underlying tumor, discontinue offending medicines in drug-induced AN.

  • After associated factors are addressed, AN is primarily a cosmetic concern.

  • Treatments to that have been used to improve the cosmetic appearance and include topical retinoids, topical hydroquinone, dermabrasion, and laser therapy.

Helpful-Hint-icon.jpg Helpful Hints

  • The vast majority of AN cases are associated with obesity.

  • Despite identical histopathology, AN does not improve with oral tetracyclines, whereas CARP responds well to this treatment.

Point-Remember-icon.jpg Points to Remember

  • Besides obesity, other causes of AN may be identified by screening for insulin resistance and diabetes.

  • When AN suddenly arises in a nonobese adult who has no family history of the condition, it is extremely important to perform a thorough workup for an underlying malignancy and identify a hidden tumor.

Carotenemia!!navigator!!

Basics

  • Carotenemia is characterized by yellow pigmentation of the skin caused by an increased level of beta-carotene in the blood. Most cases result from prolonged and excessive consumption of carotene-rich foods, such as carrots, squash, and yams (sweet potatoes).

  • Less commonly, carotenemia has been associated with diabetes mellitus and hypothyroidism.

Clinical Manifestations

  • The yellow-orange pigmentation often first appears on the palms and soles (Fig. 23.21).

  • The tip of the nose, the nasolabial folds, the palate, and other areas of the skin may become involved.

  • The sclerae are spared, which distinguishes carotenemia from jaundice.

Management-icon.jpg Management

  • Diet-induced carotenemia is a benign condition. The yellow pigmentation generally resolves with dietary changes.


Outline